The Research Council of Norway’s 10th Conference on Global Health and Vaccination Research where Bionor presents the Vacc-4x REDUC clinical trial results.
The REDUC clinical trial was partly funded by a GLOBVAC grant.
http://www.forskningsradet.no/prognett-globvac/GLOBVAC_Conference_2017/1253954270899